Among them were those with the opposite direction of change in the level of expression that formed a miRNA‒gene target pair, namely: hsa-miR-1-3p/ANXA2; hsa-miR-30c-5p/VIM; hsa-miR-28-3p/VIM; hsa-miR-654-3p/FGA; hsa-miR-30c-5p/YWHAZ; hsa-miR-1-3p/YWHAZ; hsa-miR-30c-5p/FBN1; and hsa-miR-15b-5p/MYL6, which also formed in IUGR < 34 (Table 2). The gene discussed is VIM; the disease is fetal growth restriction.